Azure OpenAI Service is now generally available. Very nice milestone in making these models widely accessible:
INNOVATION
-
Taiwan’s Gogoro battery swapping innovation revolutionizes electric mobility
By
–
What an amazing "battery swapping" #innovation in Taiwan!
— Pascal Bornet (@pascal_bornet) 17 janvier 2023
Credit: Gogoro#technology #green #tech4good pic.twitter.com/5JfqITOHIcWhat an amazing "battery swapping" #innovation in Taiwan! Credit: Gogoro
#technology #green #tech4good -
Appreciation for chibi.ai design and interface
By
–
The way you've put together http://
chibi.ai is very much up my alley. Will send you a DM -
ChatGPT API and Azure OpenAI Service Integration Coming Soon
By
–
We've learned a lot from the ChatGPT research preview and have been making important updates based on user feedback. ChatGPT will be coming to our API and Microsoft's Azure OpenAI Service soon. Sign up for updates here: https://
share.hsforms.com/1u4goaXwDRKC9-
x9IvKno0A4sk30
… -
LangChain Wolfram Alpha Integration Showcased in New Video
By
–
An awesome video by @JavaFXpert and @dralandthompson highlighting the LangChain Wolfram Alpha integration that @nickscamara_ did last week!
-
90% of Online Content Could Be AI Generated by 2025
By
–
90% of online content could be ‘generated by #AI by 2025’ #RuleoftheRobots
-
AI Technology Limitations and Expected Improvements in 2023
By
–
That is a limitation of the AI tech right now. The best way around it right now is prompting it to continue. Annoying, I know. But as the technology evolves — probably this year even — the number on a lot of those limits may be raised.
-
Programming with Natural Language While Others Ask Simple Questions
By
–
It's true, most people are asking single sentence questions still. Meanwhile I'm basically programming using natural language. What a world
-
AI Problem-Solving Examples Request
By
–
You all want to see an example? What's a problem you would want an AI to help you solve?
-
Absci’s Generative AI Advances De Novo Antibody Design
By
–
Absci’s Generative AI Approach Opens a Promising New Path for De Novo Antibody Design